Fig. 3From: The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trialThe changes in motor function (A), spasticity (B), disability (C), and quality of life (D) scores during the study periodBack to article page